Step Serial Sectioning in Head and Neck Squamous Cell Carcinoma of Unknown Primary

被引:5
|
作者
Hardman, John C. [1 ,2 ]
Harrington, Kevin [1 ,2 ]
O'Leary, Ben [1 ,2 ]
Robinson, Max [3 ]
Paleri, Vinidh [1 ,2 ,4 ]
机构
[1] Royal Marsden Natl Hlth Serv Fdn Trust, Head & Neck Unit, London, England
[2] Inst Canc Res, London, England
[3] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Dept Cellular Pathol, Newcastle Upon Tyne, England
[4] Royal Marsden Hosp, Head & Neck Unit, London SW3 6JJ, England
关键词
TRANSORAL ROBOTIC SURGERY; TONGUE BASE MUCOSECTOMY; HUMAN-PAPILLOMAVIRUS; PRIMARY SITE; WORK-UP; CANCER;
D O I
10.1001/jamaoto.2023.3993
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Importance Patients with suspected head and neck squamous cell carcinoma of unknown primary (HNSCCUP) may undergo tonsillectomy and tongue base mucosectomy (TBM) to help identify clinicoradiologically occult primary disease. It is hypothesized that when these diagnostic specimens are analyzed, conventional histopathological (CH) techniques risk missing small primary tumors that may be hidden in the tissue blocks.Objective To establish the outcomes of a step serial sectioning (SSS) histopathological technique vs CH when analyzing diagnostic tissue specimens from TBM and tonsillectomy performed for HNSCCUP.Design, Setting, and Participants The MOSES prospective multicenter noninterventional cohort study was conducted over a 25-month period from November 2019 at secondary and tertiary care ear, nose, and throat departments in the United Kingdom and included adults with clinicoradiologically occult HNSCCUP who were undergoing TBM.Intervention Conventional histopathological techniques performed on TBM and tonsillectomy specimens at participating centers, followed by SSS performed at the central laboratory.Main Outcome Identification of cancer on central histopathological review of TBM and tonsillectomy specimens.Results Tissue from 58 eligible patients was analyzed (median [range] age, 58 [47-82] years; 10 women [17%]), with 20 480 sections cut in the laboratory and 4096 sections directly examined by a pathologist (median [range], 64 [28-135] per patient). The overall identification rate for TBM following SSS according to study protocol was 50.0% (95% CI, 37.5%-62.5%) and by subgroups was 42.9% (95% CI, 21.4%-67.4%) when performed following a negative bilateral tonsillectomy, 46.7% (95% CI, 24.8%-69.9%) at the same time as bilateral tonsillectomy, and 57.1% (95% CI, 36.5%-75.5%) following historic tonsillectomy. Conventional histopathological techniques at central review identified 2 undiagnosed primary tumors and revised the diagnosis of 2 other cases (1 nonmalignant and another down staged). Step serial sectioning identified a single additional tumor: an ipsilateral synchronous tongue base tumor for which a contralateral tumor had been identified on CH. Multifocal disease was seen in 5 (8.6%); all were human papillomavirus-related and in the tongue base.Conclusions and Relevance In this multicenter cohort study of patients undergoing TBM for HNSCCUP, SSS was associated with added considerable histopathological workload with minimal additional diagnostic benefit. A second opinion for conventional histological techniques may be more beneficial. Synchronous primary disease should be considered when planning diagnostic oropharyngeal surgery for these patients.
引用
收藏
页码:118 / 126
页数:9
相关论文
共 50 条
  • [1] Unknown Primary Squamous Cell Carcinoma of the Head and Neck
    Mendenhall, William M.
    CURRENT CANCER THERAPY REVIEWS, 2005, 1 (02) : 167 - 174
  • [2] Management of unknown primary head and neck squamous cell carcinoma
    Hsing, Chih-Yu
    Liu, Shi-An
    Wang, Chen-Chi
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (05) : 637 - 638
  • [3] Evaluation and Management of Head and Neck Squamous Cell Carcinoma of Unknown Primary
    Martin, Jeffrey M.
    Galloway, Thomas J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 24 (03) : 579 - +
  • [4] Approach to the Patient with Unknown Primary Squamous Cell Carcinoma of the Head and Neck
    Moy, Jennifer
    Li, Ryan
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (12)
  • [5] Head and neck squamous cell carcinoma from an unknown primary site
    Wallace, Audrey
    Richards, Greg M.
    Harari, Paul M.
    Kirwan, Jessica M.
    Morris, Christopher G.
    Katakam, Haritha
    Mendenhall, William M.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2011, 32 (04) : 286 - 290
  • [6] Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck
    Hung, Yu-Hsuan
    Liu, Shih-An
    Wang, Chen-Chi
    Wang, Ching-Ping
    Jiang, Rong-San
    Wu, Shang-Heng
    PLOS ONE, 2018, 13 (10):
  • [7] Approach to the Patient with Unknown Primary Squamous Cell Carcinoma of the Head and Neck
    Jennifer Moy
    Ryan Li
    Current Treatment Options in Oncology, 2020, 21
  • [8] Commentary on "Management of unknown primary head and neck squamous cell carcinoma"
    Mendenhall, William M.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (05) : 638 - 639
  • [9] Prognostic factors of unknown primary head and neck squamous cell carcinoma
    Huang, Chun-Chi
    Tseng, Fen-Yu
    Yeh, Te-Huei
    Wen, Yu-Hsuan
    Hsu, Chuang-Jen
    Ko, Jeng-Yuh
    Lou, Pei-Jen
    Chen, Yuh-Shyang
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 139 (03) : 429 - 435
  • [10] Squamous cell carcinoma from an unknown head and neck primary site
    Patel, Rajan S.
    Clark, Jonathan
    Wyten, Rebecca
    Gao, Kan
    O'Brien, Christopher J.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2007, 133 (12) : 1282 - 1287